Anthony D. D’Urzo

I would like to congratulate Dr Samir Gupta for his excellent Choosing Wisely Canada article1 pertaining to diagnosing asthma and chronic obstructive pulmonary disease (COPD) and the importance of pulmonary function testing in this context. I have had the pleasure of working with Dr Gupta in areas dealing with this subject and I have learned a great deal from him about the challenges that we face when it comes to diagnosing asthma and COPD in the primary care setting.

Research ArticleClinical Review Anthony D. D’Urzo, David Price, Peter Kardos and M.

Article highlights Aclidinium/formoterol 400/12 µg twice-daily has a safety profile comparable with its monotherapies and has been shown to improve lung function, health-related quality of life (HRQoL), and respiratory symptoms, as well as reducing exacerbation rates versus monotherapies and/or placebo in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) [16–19 Singh D, Jones PW, Bateman ED, et al.